LED demand ushers in the summer market is fiercely competitive

The latest quotation from LEDinside, the green energy business unit of TrendForce, a global market research institute, shows that the decline in the price of LEDs for lighting in the second quarter of 2014 is between 3 and 7; the decline in the price of backlight LEDs is about 5-10, which is due to the direct The LED market is highly competitive, with an average drop of 13.
In the second quarter, the price of LEDs for high-power and medium-power lighting continued to decline. The Korean manufacturers represented by Samsung in the mid-power 5630 still adopted a low-price strategy to seize the market; while the decline in high-power prices was more obvious than other products, especially high. Brightness LED (120-140lm) overall decline of 7; As for the COB part, product line expansion and performance improvement for each manufacturer's development focus, overall, at least 30W below the product line needs to be complete, lighting manufacturers have the willingness to place orders . Guo Zhihao, an associate researcher at LEDinside, said that the average visibility of backlight LED orders is 1-2 months, and chip and package manufacturers are rushing. Despite the high-end rate of LED manufacturers, the profit of the camp is affected by the 10-15 price drop per year, and the profit margin is still limited. Therefore, LED manufacturers will see whether the orders in the third quarter need to be expanded due to visibility. Generally speaking, it is conservative and wait-and-see attitude.
Guo Zhihao further stated that LED manufacturers' efforts this year are aimed at actively developing niche markets (lights, FlashLEDs and UVLEDs) and high value-added LEDs (high color saturation backlight LEDs and high color rendering LEDs) to gradually reduce The proportion of backlight products. Finally, in terms of kinetic energy, the demand for the large-size and 4K high-resolution TV market in Brazil in June increased, and the application of lighting in the nuclear energy issue fermentation and energy-saving measures is expected to accelerate the penetration of LED lighting.

Attenuated Vaccines (Live)

Influenza Vaccine, Live, Nasal, Freeze-dried is a cooperative project with the WHO, which has been included in Global Action Plan for Influenza Vaccines (GAP)[1]. Hundreds of millions of doses have been used in the world, and Changchun BCHT Biotechnology Co. has the exclusive right of production and

operation in China.

Intranasal spray administration, no injection and no pain

The vaccine is inoculated by nasal spray, equipped with nasal spray device, and only needs to spray once a year in two nostrils to prevent influenza.

Mucosal immunity + Cellular immunity + Humoral immunity

After influenza virus attacks human body, it widely exists in nasal cavity, respiratory tract and other mucosal parts, as well as in body fluids and cells.

Vaccination of Influenza Vaccine, Live, Nasal, Freeze-dried can quickly stimulate the triple immune response of human body, and carry out defense

against viruses in different parts:

·Intranasal administration can produce mucosal immunity (IgA antibody), which forms the first immune defense line in the nasal cavity.

·Produce humoral immunity (IgG antibody) to remove influenza virus from body fluids.

·Produce cellular immunity (T cells) to remove influenza virus from cells

3+N More extensive protection

The production strains are recommended and supplied by the WHO every year.

The vaccine can not only effectively resist the vaccine strain, but also produce cross immunity to other subtypes of influenza virus.

Produced with SPF embryonated eggs

SPF

The chick embryos for vaccine production comes from SPF (specific pathogen free) chicken flocks, so the risk of exogenous pathogenic microorganism

pollution is excluded.

Free of inactivator, split agent and preservative

High protection and fast antibody production

This is the first influenza vaccine in China that has been evaluated by the protection effect of etiology in clinical stage. The protective effect of phase III

clinical trial is consistent with the literature.

First, the immune barrier was formed in the nasal mucosa after LAIV vaccination. It has been reported that the antibody of nasal mucosa can be

produced in 3 days, which greatly shortens the time for vaccine to produce

protective effect.

Influenza Vaccine Freeze-Dried,Liquid Influenza Vaccine,Influenza Vaccine Live,Cinfluenza Vaccine Live

Changchun BCHT Biotechnology Co. , https://www.ccbcht.net